Member-only story

BG00012: BG-12 - Get the Beneficial Effects Now! Biogen's New Hope for Multiple Sclerosis

Jared Powell

·9.5k Followers· Follow

Published in BG00012 (BG 12) Get The Beneficial Effects Now Biogens New Hope For Multiple Sclerosis (Little M S Nosey 1)

5 min read

958 View Claps

61 Respond

Save

Listen

BG00012 (BG 12) Get the Beneficial Effects Now Biogens New Hope for Multiple Sclerosis (Little M S Nosey 1)

BG00012 (BG-12) Get the Beneficial Effects Now!– Biogens’ New Hope for Multiple Sclerosis (Little M.S. Nosey Book 1)

by Max Sidorov

4.2 out of 5

Language	:	English
File size	:	343 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	52 pages
Lending	:	Enabled

BG00012 (BG 12) For Multiple Sclerosis BG00012 (BG 12) Get The Beneficial Effects Now Biogens New Hope For Multiple Sclerosis (Little M S Nosey 1)

What is BG00012 (BG-12)?

BG00012 (BG-12) is a first-of-its-kind treatment developed by Biogen for the management of multiple sclerosis (MS). It is a monoclonal antibody that targets the CD20 molecule on the surface of B-cells, a type of immune cell that plays a significant role in the development of MS.

When BG-12 binds to CD20, it triggers the immune system to destroy the B-cells, thereby reducing their ability to attack the nervous system. This targeted approach has the potential to slow down the progression of MS and alleviate symptoms.

How Does BG-12 Work?

MS is an autoimmune disFree Download characterized by an overactive immune system that attacks the myelin sheath, the protective covering around nerve fibers. This damage disrupts communication between the brain and spinal cord, leading to a range of symptoms.

BG-12 works by targeting and eliminating B-cells, which are a type of immune cell that contributes to the inflammatory response in MS. By reducing the number of B-cells, BG-12 helps to calm the overactive immune system and protect the myelin sheath.

Benefits of BG-12 for MS

Clinical trials have shown that BG-12 can provide significant benefits for people with MS, including:

Reduced relapse rates
Improved physical function
Slowed disease progression
Improved quality of life

BG-12 has been approved by the FDA for the treatment of relapsing-remitting MS (RRMS) and clinically isolated syndrome (CIS),a condition that often precedes MS.

How to Get BG-12 Treatment

If you have been diagnosed with MS and are interested in BG-12 treatment, talk to your doctor to determine if this therapy is right for you. BG-12 is administered as an intravenous infusion every 6 months.

Your doctor will monitor your response to treatment and make adjustments as necessary. Regular follow-up appointments are essential to ensure the continued effectiveness of BG-12.

The Future of MS Treatment

BG-12 represents a major advancement in the treatment of MS. Its ability to target the underlying immune response and alleviate symptoms offers new hope for people living with this condition.

Ongoing research is exploring the potential of BG-12 for treating other autoimmune diseases, and scientists are optimistic about its potential to improve the lives of patients worldwide.

BG00012 (BG-12) is a groundbreaking treatment that offers new hope for people with multiple sclerosis. Its unique mechanism of action, proven benefits, and ease of administration make it a promising option for managing MS and improving quality of life.

If you are interested in learning more about BG-12 or accessing this innovative therapy, talk to your doctor today.

BG00012 (BG-12) Get the Beneficial Effects Now!– Biogens’ New Hope for Multiple Sclerosis (Little M.S. Nosey Book 1)

by Max Sidorov

4.2 out of 5